Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy

by Ysios Capital

Vivet Therapeutics announces the financing of EUR 4.9 million received from the French government to advance the development of a gene therapy for the treatment of cerebrotendinous xanthomatosis (CTX)...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Una molécula experimental logra ‘repr...

by CSIC - Centro Superior de Investigaciones Científicas

Un estudio del Instituto de Neurociencias (CSIC-UMH) muestra en modelo...

Photos Stream